Category: Health & Medicines > Medicines > Tacrolimus
Country/Region: China State/Province: Beijing
Main Products: Apixaban, Apremilast, API, Medical Intermediate
Business Type: Exporter, Services
Year Established: 2012
Employees: 51 - 100 People
Plant Area: 3,000-5,000 square meters
Main Markets: South America 10% Africa 11% Eastern Asia 8% Domestic Market 8% North America 8% Eastern Europe 8% Southern Europe 9% Mid East 10% Northern Europe 10% Oceania 18%
Trade Capacity: FOB, CFR, Express Delivery
Contract Manufacturing: Design Service Offered
Nearest Port: Xian
Annual Revenue: US$10 Million - US$50 Million
Total Revenue: US$10 Million - US$50 Million
Export Revenue: Above US$100 Million
Annual Output: US$5 Million - US$10 Million
Registered Capital: US$2.5 Million - US$5 Million
Export Percentage: 91% - 100%
Payment Modes: USD, EUR, HKD
Lead Time: 23 days
Import/Export Mode: Using an agent